11. A Decade of HIV-1 Drug Resistance in the United States: Trends and Characteristics in a Large Protease/Reverse Transcriptase and Co-Receptor Tropism Database from 2003 to 2012. Issue 4 (May 2014) Authors: Paquet, Agnes C; Solberg, Owen D; Napolitano, Laura A; Volpe, Joseph M; Walworth, Charles; Whitcomb, Jeannette M; Petropoulos, Christos J; Haddad, Mojgan Journal: Antiviral therapy Issue: Volume 19:Issue 4(2014) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. A favipiravir-induced angioedema and urticaria in a COVID-19 patient. Issue 6 (20th December 2022) Authors: Ergur Ozturk, Figen; Ozturk, Ayperi; Ates, Hale Journal: Antiviral therapy Issue: Volume 27:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. A Meta-Analysis of Laninamivir Octanoate for Treatment and Prophylaxis of Influenza. Issue 2 (February 2018) Authors: Higashiguchi, Masayoshi; Matsumoto, Tomoshige; Fujii, Takashi Journal: Antiviral therapy Issue: Volume 23:Issue 2(2018) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. A Non-Randomized Multicentre Trial of Human Immune Plasma for Treatment of Hantavirus Cardiopulmonary Syndrome Caused by Andes Virus. Issue 4 (May 2015) Authors: Vial, Pablo A; Valdivieso, Francisca; Calvo, Mario; Rioseco, M Luisa; Riquelme, Raul; Araneda, Andres; Tomicic, Vinko; Graf, Jerónimo; Paredes, Laura; Florenzano, Matias; Bidart, Teresa; Cuiza, Analia; Marco, Claudia; Hjelle, Brian; Ye, Chunyan; Hanfelt-Goade, Diane; Vial, Cecilia; Rivera, Juan C... Journal: Antiviral therapy Issue: Volume 20:Issue 4(2015) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. A Novel Ritonavir Paediatric Powder Formulation is Bioequivalent to Ritonavir Oral Solution with a Similar Food Effect. Issue 4 (May 2015) Authors: Salem, Ahmed Hamed; Chiu, Yi-Lin; Valdes, Joaquin M; Nilius, Angela M; Klein, Cheri E Journal: Antiviral therapy Issue: Volume 20:Issue 4(2015) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. A Pharmacokinetic Comparison of Adult and Paediatric Formulations of Raltegravir in Healthy Adults. Issue 6 (August 2014) Authors: Rhee, Elizabeth G; Rizk, Matthew L; Brainard, Diana M; Gendrano, Isaias N; Jin, Bo; Wenning, Larissa A; Wagner, John A; Iwamoto, Marian Journal: Antiviral therapy Issue: Volume 19:Issue 6(2014) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. A Pharmacokinetic/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir against Chronic HCV. Issue 5 (July 2015) Authors: Canini, Laetitia; Chatterjee, Anushree; Guedj, Jeremie; Lemenuel-Diot, Annabelle; Brennan, Barbara; Smith, Patrick F; Perelson, Alan S Journal: Antiviral therapy Issue: Volume 20:Issue 5(2015) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-Nucleoside Polymerase Inhibitor. Issue 4 (May 2018) Authors: Canini, Laetitia; Lemenuel-Diot, Annabelle; Brennan, Barbara J; Smith, Patrick F; Perelson, Alan S Journal: Antiviral therapy Issue: Volume 23:Issue 4(2018) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. A Phase 1 randomized study of GSK3732394, an investigational long-acting biologic treatment regimen for HIV-1 infection. Issue 5 (3rd October 2022) Authors: Krystal, Mark; Chabria, Shiven; Austin, Daren; Wolstenholme, Allen; Wensel, David; Lataillade, Max; Abberbock, Judah; Baker, Mark; Ackerman, Peter Journal: Antiviral therapy Issue: Volume 27:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. A Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C Patients. Issue 3 (April 2013) Authors: Lawitz, Eric J; Hill, John M; Marbury, Thomas; DeMicco, Michael P; Delaney, William; Yang, Jenny; Moorehead, Lisa; Mathias, Anita; Mo, Hongmei; McHutchison, John G; Rodriguez-Torres, Maribel; Gordon, Stuart C Journal: Antiviral therapy Issue: Volume 18:Issue 3(2013) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗